课题基金 / 基金详情

Lnc-PPP2R1B作为增强子RNA招募剪切体复合物调控干细胞成骨分化的机制研究

批准号:
82072084
项目类别:
面上项目
资助金额:
56.0 万元
负责人:
彭淑平
依托单位:
学科分类:
组织器官再生机制与调控
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
彭淑平

项目摘要

结项摘要

彭淑平的其他基金

相似基金

相关文献

中文摘要
干细胞研究是当今生命科学前沿和热点,而干细胞分化调控方兴未艾,尤其是LncRNA在定向分化中作用和机制尚不清楚。前期研究发现间充质干细胞定向成骨分化时Lnc-PPP2R1B显著上调;其过表达上调邻近编码基因PPP2R1B及成骨转录因子RUNX2和OSX,促进成骨分化,敲减其则抑制成骨;特异性招募剪切复合物组分hnRNPLL和SRSF1,呈相分离样定位在核斑,因此提出了Lnc-PPP2R1B通过招募HnRNPLL等调控PPP2R1B pre mRNA剪切促进干细胞成骨分化的假说。本项目拟通过基因编辑、单分子超分辨成像、Gro-seq和Micro-CT等技术查明Lnc-PPP2R1B如何通过相分离调控PPP2R1B剪切,明确其是否作为eRNA活化PPP2R1B表达,稳定下游β-catenin入核活化,促进RUNX2和OSX的转录调控成骨分化的分子机制,为治疗骨缺损以及骨退行性病变提供新的思路。
英文摘要
Stem cells and regenerative medicine are the frontier and hotspot in the field of life science, and the regulation of stem cell differentiation is in the ascendant. In particular, the role and mechanism of long noncoding RNA in linage commitment are unclear. It was found in our previous studies that lnc-PPP2R1B was significantly up-regulated when MSCs were induced to differentiate into osteoblasts; overexpression of lnc-PPP2R1B could up-regulate the adjacent coding genes PPP2R1B and osteogenic specific transcription factors RUNX2 and OSX, and promote osteogenic differentiation, and knockdown of the gene inhibited osteogenesis; it specifically bond with HNRNPLL and SRSF1, and it was located in the nuclear speckle in a phase separation manner. Based on these findings, a hypothesis has been proposed that lnc-PPP2R1B promotes the osteogenic differentiation of MSCs through binding HnRNPLL and regulating the alternative splicing of PPP2R1B. This project aims to find out how lnc-PPP2R1B can regulate the alternative splicing of PPP2R1B through phase separation by gene editing, single molecule super-resolution imaging, Gro-seq and micro CT at the cellular, tissue and animal levels, to determine whether it can activate the expression of PPP2R1B as an enhancer RNA, and to find out how lnc-PPP2R1B can promote the transcription of RUNX2 and OSX by regulating PPP2R1B to stabilize the entry to nucleaus of β-Catenin, thus promote the osteogenic differentiation. This study will provide new ideas for the treatment of bone defects and bone degenerative bone diseases.
在自然科学基金委的资助下,申请人承担的项目“Lnc-PPP2R1B作为增强子RNA招募剪切体复合物调控干细胞成骨分化的机制研究”,以Lnc-PPP2R1B为切入点,从细胞模型、分子水平以及实验动物等不同层面,查明了Lnc-PPP2R1B抑制干细胞成骨分化的作用机制;发现了Lnc-PPP2R1B与HNRNPLL结合介导PPP2R1B-201/203转录本的剪切,上调β-catenin的去磷酸化和核易位,增强关键关键成骨因子Runx2和OSX的变大,从而促进成骨分化;明确了Lnc-PPP2R1B体内促进成骨分化的作用。本项目的研究结果提示增强Lnc-PPP2R1B表达水平促进成骨分化的策略,为再生医学领域骨缺损修复和成骨障碍性疾病的治疗提供新的思路。目前相关研究成果发表SCI研究论文17篇,代表性论文发表在Cell Death Dis等国际期刊;申请并授权国家专利3项;获得奖励2项;培养研究生12名(其中6名研究所完成了其学位论文)。
子宫内壁纤维化防治生物材料的研发
  • 批准号:
    2025JK2127
  • 项目类别:
    省市级项目
  • 资助金额:
    0.0万元
  • 批准年份:
    2025
  • 负责人:
    彭淑平
  • 依托单位:
LncRNA ODIR1通过组蛋白修饰调控Osterix参与干细胞成骨分化的 机制研究
  • 批准号:
    81871498
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2018
  • 负责人:
    彭淑平
  • 依托单位:
Lin28A/ROCK2交互作用靶向RAN和HSBP1调控卵巢癌干细胞的功能及分子机制研究
  • 批准号:
    81572577
  • 项目类别:
    面上项目
  • 资助金额:
    65.0万元
  • 批准年份:
    2015
  • 负责人:
    彭淑平
  • 依托单位:
血浆/血清异常表达miR-17, miR-20a, miR-29c, 和miR-223在鼻咽癌中的临床意义和功能研究
  • 批准号:
    81372366
  • 项目类别:
    面上项目
  • 资助金额:
    16.0万元
  • 批准年份:
    2013
  • 负责人:
    彭淑平
  • 依托单位:
国内基金
海外基金